Endocrinology

Dr. Bobby Lazzara reviews a small study testing the effects of psilocybin on depression and anxiety in patients with life-threatening cancer.

The FDA expands indication for a glucose monitoring system to replace finger-stick blood glucose testing for patients at least 2 years old who are being treated for diabetes.

Being overweight worsens osteoarthritis and diabetics often have extra weight. But a new study found that it is not weight alone that puts these patients at risk of the joint ailment.

Baseline glycemic control can help individuals with type 2 diabetes achieve more significant body-composition results from their exercise regimens.

In a world where insurance plans constantly change, it is important to remind patients that they need to understand their policies.

Results of a 10-year study on bladder cancer risk with pioglitazone might be better than the five-year results led the US Food and Drug Administration to re-affirm that the danger is real--though slightly less than the preliminary data showed.

Extracorporeal shock therapy helped patients with diabetes improve their range of motion when suffering from "frozen shoulder" a study in Italy found.

Competitiveness, compulsiveness, ambitiousness – these are some key characteristics of physicians that increase stress and burnout.

Synjardy XR, a combination of empagliflozin and metformin hydrochloride, was approved this afternoon by the FDA for glucose management in type 2 diabetics. The drug is a collaboration between Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company.

Sitagliptin tablets proved more convenient and equally safe and effective as insulin injections in achieving glycemic control for people with diabetes admitted to hospitals for medical care or surgery, a five-center study found.

Though all obese women are treated as though they are at high risk of getting diabetes during pregnancy, that's not true. Only a quarter of them do. A UK team has figured out how to assess risk.

A retrospective analysis of nutrition studies showed magnesium can reduce heart failure and diabetes risk. The key is dosage, a team found.

Age-related macular degeneration, the leading cause of blindness in the developed world, has long been linked to diet and obesity. Recently, we came closer to understanding just exactly why that is.

Many women believe that estrogen in birth control pills is causing them to gain weight, however, studies concluded that this is a temporary side effect more times than not – and the “gain” is water retention, not fat.

A new analysis indicates that a 25% reduction in exposure to certain household chemicals would reduce diabetes cases by approximately 13%, enough to save billions of dollars in annual health costs.

While one study found that taking vitamin D during pregnancy may hinder early ADHD symptoms, another recent study believes that gestational use of diabetes medications may lead to them.

As if egg-laying Australian mammals with webbed feet weren't fascinating enough, it turns out that their venom contains an insulin-stimulating peptide resistant to the forces that usually shorten its effectiveness in humans. Yes, they have venom.

The MD Magazine editors rounded up the 10 best stories from November – did you read them all?

As the field of medical ethics continues to expand, its use can be seen in everything from general medical conditions to end of life considerations.

Scientists found that amyloid beta proteins accumulate in the retinas of AMD patients – the same types of proteins that settle in the brains of people with Alzheimer’s disease.

Many previous studies have shown that smoking causes lung cancer, but a recently published report explained that heavy smokers with diabetes also have an increased risk of death unrelated to lung cancer.

With diabetes affecting so many parts of a patient's life sometimes it is not enough for one provider to help them manage the condition.

It can be easy for providers to be lost in numbers as they go through a busy day in the clinic. However, there is evidence to suggest that finding different ways to help patients beyond symptom management can do as much if not more to help improve quality of life overall.

Patients with diabetes face a number of challenges in their daily life, especially monitoring their blood glucose levels. There is work being done in the medical community to monitor other potential issues that can affect quality of life overall and how to address them.

Novo Nordisk’s Xultophy combines a previously marketed basal insulin with a glucagon-like peptide-1 receptor agonist, and was yesterday accepted by the FDA. The company plans to have the drug on the market in 2017.

Researchers are getting closer to understanding the pathogenesis of one type of age-related macular degeneration.

For men afflicted with type 2 diabetes and at high risk for heart attacks; however, relief might be found in an unlikely source – the erectile dysfunction drug Viagra (sildenafil).

Despite a heightened risk of diabetes, Asian Americans are least likely to be screened for the disease, according to a new study from the University of Chicago.

As bills mounted and reimbursement diminished, doctors grappled with the decision of whether or not to close their private practice.

Research using mouse models demonstrated that a high-fat diet increased intestinal permeability, which led to increases in circulating and local inflammatory cytokines, and increased choroidal neovascularization.